Crossmark

Mendelian Susceptibility to Mycobacterial Disease Caused by a Novel Founder IL12B Mutation in Saudi Arabia

Crossref DOI link: https://doi.org/10.1007/s10875-018-0490-2

Published Online: 2018-03-27

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alodayani, Abdulrahman N.

Al-Otaibi, Abdulnasir M.

Deswarte, Caroline

Frayha, Husn Habib

Bouaziz, Matthieu

AlHelale, Maryam

Le Voyer, Tom

Nieto-Patlan, Alejandro

Rattina, Vimel

AlZahrani, Mofareh

Halwani, Rabih

Al Sohime, Fahad

Al-Mousa, Hamoud

Al-Muhsen, Saleh

Alhajjar, Sami H.

Dhayhi, Nabil S.

Abel, Laurent

Casanova, Jean-Laurent

Bin-Hussain, Ibrahim

AlBarrak, May S.

Al-Jumaah, Suliman A.

Bustamante, Jacinta
Funding

Funding for this research was provided by:

ANR-GENMSMD (ANR-16-CE17-0005-01)

National Institute of Allergy and Infectious Disea (5R01AI089970-02)

The Rockefeller University Center for Clinical and Translational Science (8UL1TR000043)
License Information

Text and Data Mining valid from 2018-03-27
More Information

Article History

Received: 7 December 2017

Accepted: 16 March 2018

First Online: 27 March 2018

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

: Informed consent for participation in this study was obtained in accordance with local regulations, with approval from the IRB. The experiments described here were performed in France, in accordance with local regulations, and with the approval of the IRB of Necker Hospital for Sick Children, France.

: Written informed consent was obtained from the patients.